Viewing Study NCT06110793


Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2025-12-27 @ 12:37 PM
Study NCT ID: NCT06110793
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-10-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module